approval · primary record
INFLIXIMAB-DYYB
FDA · BLA · 2025-09-03
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-09-03 |
| Brand | INFLECTRA |
| Sponsor | CELLTRION INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:40:42.495Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:INFLIXIMAB-DYYB:2025-09-03
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Infliximab-Dyyb · compound